Literature DB >> 23957842

Evaluation of inhibitory effect of phlorotannins from Ecklonia cava on triglyceride accumulation in adipocyte.

Haejin Kim1, Chang-Suk Kong, Jung Im Lee, Hojun Kim, Seungoh Baek, Youngwan Seo.   

Abstract

In the present study, a methanolic extract of Ecklonia cava and its solvent-partitioned fractions were evaluated for their antiadipogenic effect in 3T3-L1 adipocytes. One of them, the n-BuOH fraction, effectively reduced lipid accumulation and glucose consumption. In addition, the presence of the n-BuOH fraction in adipocytes suppressed the regulations of adipogenic transcription factors, PPARγ and SREBP1c, and adipogenic specific genes, FABP4, FABP1, FAS, LPL, HSL, and ACS1. Further purification of n-BuOH fractions led to the isolation of six phlorotannins (1-6). The six phlorotannins effectively suppressed triglyceride accumulation. Comparative analysis showed that lipid accumulation in adipocytes was dramatically attenuated in the presence of eckstolonol (4).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23957842     DOI: 10.1021/jf401454m

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  11 in total

1.  Anti-obesity effects of pectinase and cellulase enzyme‑treated Ecklonia cava extract in high‑fat diet‑fed C57BL/6N mice.

Authors:  In-Hye Kim; Jung-Wook Choi; Min-Kyeong Lee; Chang-Ju Kwon; Taek-Jeong Nam
Journal:  Int J Mol Med       Date:  2017-11-28       Impact factor: 4.101

2.  Enzyme-treated Ecklonia cava extract inhibits adipogenesis through the downregulation of C/EBPα in 3T3-L1 adipocytes.

Authors:  In-Hye Kim; Taek-Jeong Nam
Journal:  Int J Mol Med       Date:  2017-01-26       Impact factor: 4.101

3.  Phlorotannins from Ecklonia cava Attenuates Palmitate-Induced Endoplasmic Reticulum Stress and Leptin Resistance in Hypothalamic Neurons.

Authors:  Seyeon Oh; Myeongjoo Son; Junwon Choi; Chang Hu Choi; Kook Yang Park; Kuk Hui Son; Kyunghee Byun
Journal:  Mar Drugs       Date:  2019-10-09       Impact factor: 5.118

Review 4.  Recent advances in pharmacological research on Ecklonia species: a review.

Authors:  Prashamsa Koirala; Hyun Ah Jung; Jae Sue Choi
Journal:  Arch Pharm Res       Date:  2017-08-24       Impact factor: 4.946

5.  Polyphenol-Rich Fraction of Ecklonia cava Improves Nonalcoholic Fatty Liver Disease in High Fat Diet-Fed Mice.

Authors:  Eun-Young Park; Hojung Choi; Ji-Young Yoon; In-Young Lee; Youngwan Seo; Hong-Seop Moon; Jong-Hee Hwang; Hee-Sook Jun
Journal:  Mar Drugs       Date:  2015-11-12       Impact factor: 5.118

6.  Phlorofucofuroeckol A from Edible Brown Alga Ecklonia Cava Enhances Osteoblastogenesis in Bone Marrow-Derived Human Mesenchymal Stem Cells.

Authors:  Jung Hwan Oh; Byul-Nim Ahn; Fatih Karadeniz; Jung-Ae Kim; Jung Im Lee; Youngwan Seo; Chang-Suk Kong
Journal:  Mar Drugs       Date:  2019-09-21       Impact factor: 5.118

7.  Identifying Phlorofucofuroeckol-A as a Dual Inhibitor of Amyloid-β25-35 Self-Aggregation and Insulin Glycation: Elucidation of the Molecular Mechanism of Action.

Authors:  Su Hui Seong; Pradeep Paudel; Hyun Ah Jung; Jae Sue Choi
Journal:  Mar Drugs       Date:  2019-10-23       Impact factor: 5.118

Review 8.  Potential Anti-Aging Substances Derived from Seaweeds.

Authors:  Lei Cao; Sang Gil Lee; Kwon Taek Lim; Hyeung-Rak Kim
Journal:  Mar Drugs       Date:  2020-11-18       Impact factor: 5.118

9.  Preparation, Characterization and Antioxidant Activities of Kelp Phlorotannin Nanoparticles.

Authors:  Ying Bai; Yihan Sun; Yue Gu; Jie Zheng; Chenxu Yu; Hang Qi
Journal:  Molecules       Date:  2020-10-05       Impact factor: 4.411

10.  Dieckol Ameliorates Aβ Production via PI3K/Akt/GSK-3β Regulated APP Processing in SweAPP N2a Cell.

Authors:  Jeong-Hyun Yoon; Nayoung Lee; Kumju Youn; Mi Ra Jo; Hyeung-Rak Kim; Dong-Seok Lee; Chi-Tang Ho; Mira Jun
Journal:  Mar Drugs       Date:  2021-03-15       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.